Harnessing proteasome dynamics and allostery in drug design.
about
Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategiesInterplay between Structure and Charge as a Key to Allosteric Modulation of Human 20S Proteasome by the Basic Fragment of HIV-1 Tat ProteinSubstituted quinolines as noncovalent proteasome inhibitors.Electrostatic Map Of Proteasome α-Rings Encodes The Design of Allosteric Porphyrin-Based Inhibitors Able To Affect 20S Conformation By Cooperative Binding.
P2860
Harnessing proteasome dynamics and allostery in drug design.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Harnessing proteasome dynamics and allostery in drug design.
@en
type
label
Harnessing proteasome dynamics and allostery in drug design.
@en
prefLabel
Harnessing proteasome dynamics and allostery in drug design.
@en
P2860
P356
P1476
Harnessing proteasome dynamics and allostery in drug design
@en
P2093
Maria Gaczynska
P2860
P304
P356
10.1089/ARS.2013.5816
P577
2014-02-21T00:00:00Z